Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
50%(2 trials)

Phase Distribution

Ph early_phase_1
1
25%
Ph not_applicable
3
75%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

The Medication Experience Study

NCT01702883
completednot_applicable

Oral Psoriasis Treatment Adherence and Intervention Study

NCT02850900
completedearly_phase_1

Using an Internet Study to Improve Adherence for Psoriasis Patients

NCT01802580
completednot_applicable

A Novel Method to Improve Acne Outcomes

NCT01176955

Clinical Trials (4)

Showing 4 of 4 trials
NCT01702883Not Applicable

The Medication Experience Study

Completed
NCT02850900Not Applicable

Oral Psoriasis Treatment Adherence and Intervention Study

Completed
NCT01802580Early Phase 1

Using an Internet Study to Improve Adherence for Psoriasis Patients

Completed
NCT01176955Not Applicable

A Novel Method to Improve Acne Outcomes

Completed

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4